Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy

Janine R. Danko*, William R. Gilliland, R. Scott Miller, Catherine F. Decker

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Abstract

Tumor necrosis factor-α inhibitors are important adjunctive therapies for rheumatologic diseases. These agents increase the risk for granulomatous disease. We present a case of a woman with severe rheumatoid arthritis on infliximab who developed multiple nodular skin lesions. Biopsies grew Mycobacterium marinum. New lesions developed through therapy, necessitating surgical debulking.

Original languageEnglish
Pages (from-to)252-255
Number of pages4
JournalScandinavian Journal of Infectious Diseases
Volume41
Issue number4
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy'. Together they form a unique fingerprint.

Cite this